A Novel Function of Siglec-9 A391C Polymorphism on T Cell Receptor Signaling
Author(s) -
Kyung Ah Cheong,
YoonSeok Chang,
Joo Young Roh,
Bum-Jun Kim,
Myung-Nam Kim,
Youn Min Park,
HaiJin Park,
Nam Doo Kim,
ChangHoon Lee,
AiYoung Lee
Publication year - 2010
Publication title -
international archives of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.696
H-Index - 100
eISSN - 1423-0097
pISSN - 1018-2438
DOI - 10.1159/000320225
Subject(s) - siglec , t cell receptor , jurkat cells , biology , sialic acid , receptor , signal transduction , c type lectin , transfection , t cell , microbiology and biotechnology , phosphorylation , immunology , biochemistry , genetics , cell culture , immune system
Sialic-acid-binding immunoglobulin-like lectins (Siglecs) are the best-characterized immunoglobulin-type lectins. There is a growing amount of data linking Siglec and autoimmune diseases. The recently identified Siglec-9 inhibits T cell receptor (TCR)-mediated signaling which has been demonstrated by site-directed mutagenesis. In human Siglec-9, at least 8 nonsynonymous SNPs have been detected without functional studies. This study examined the SNP(s) related to TCR-mediated signaling.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom